News

World's first primary standard developed for molecular radiotherapy

The new primary standard for MRT
The new primary standard for MRT – Courtesy of NPL

Researchers from EMRP project develop the world's first primary standard for molecular radiotherapy (MRT) to treat cancer

The new standard will help improve the consistency of MRT treatments, in which radioactive molecules, or radiopharmaceuticals, are injected directly into a patient's body to target and kill cancerous cells. Such standardisation is vital to encourage more widespread use of MRT and develop new and improved radiopharmaceuticals.

Like any form of radiotherapy, the success of MRT relies on the delivery of an extremely precise dose of radiation. The goal is to maximise the dose delivered to the tumour, while minimising damage to surrounding healthy tissue. However, in contrast to other forms of radiotherapy, dosimetry for MRT is not well established. Researchers from EMRP project Metrology for molecular radiotherapy (HLT11 MetroMRT) developed the new standard.  A gas-filled ionisation chamber, containing two parallel electrodes an adjustable distance apart, enables the user to measure the absorbed radiation dose from a radioactive solution.

Select your area of interest
Biogas workshop showcased successful metrology capability
2017-04-25

Discussions at EMRP workshop between industry and metrologists addresses ongoing biogas metrology requirements more

EURAMET addresses metrology needs in health sector
2017-04-05

World Health Day, celebrated on 7 April, marks the anniversary of the World Health Organisation (WHO) more

World's first primary standard developed for molecular radiotherapy
2017-04-05

Researchers from EMRP project develop the world's first primary standard for molecular radiotherapy (MRT) to treat cancer more

Nanoparticle research receives best poster awards
2017-03-30

EMPIR project researchers are recognised for their work on nanoparticle characterisation. more

Page 1 of 91.